Clinical trial
ATHN 9: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People With Severe Von Willebrand Disease (VWD)
NCT03853486 is registered in ClinicalTrials.gov with American Thrombosis and Hemostasis Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ATHN 9: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People With Severe Von Willebrand Disease (VWD)
- Lead sponsor
- American Thrombosis and Hemostasis Network
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 18, 2019
- Completion date
- June 26, 2026
- Enrollment
- 108 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.